Neuroimaging Core
神经影像核心
基本信息
- 批准号:10461090
- 负责人:
- 金额:$ 70.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAmyloidAmyloid beta-ProteinAngiographyAutopsyBiologicalBiological MarkersBlood VesselsBrainBrain imagingCerebral hemisphereClinicalClinical ResearchCollaborationsConsensusDataData ProvenanceDatabasesDevelopmentDimensionsDiseaseDisease ProgressionDoctor of MedicineDoctor of PhilosophyEvaluationFunctional ImagingGeneticGenomicsHeterogeneityHistopathologyImageImage AnalysisIncidenceInfrastructureInterventionLightLinkMRI ScansMagnetic Resonance ImagingMeasuresMetadataMethodsModalityMolecularMonitorNerve DegenerationNeurodegenerative DisordersOptical Coherence TomographyParticipantPathologyPhenotypePlasmaPositron-Emission TomographyProceduresProcessProtocols documentationReproducibilityResearchResearch InfrastructureResearch PersonnelResearch SubjectsResourcesRetinaRiskSamplingScanningScientistSlideSpecificityStagingStructureTissuesTracerTraining and EducationTranslationsUniversitiesUpdateValidationWashingtonbasebiomarker developmentbrain behaviorbrain magnetic resonance imagingbrain tissueclinical centercohortdata infrastructuredata integrationdata managementdata sharingdigitaldigital pathologyeducation researchflexibilityimage guidedimaging informaticsimaging studyin vivoinformatics infrastructureinsightischemic lesionmethod developmentmolecular imagingmorphometrymultimodalityneuroimagingneuroimaging markerneuroinflammationneuropathologyneurovascularnoveloutreachperfusion imagingpre-clinicalradioligandrecruitretinal imagingstatisticstau Proteins
项目摘要
Neuroimaging Core Project Summary
Because of their tolerability, versatility, and spatial specificity, neuroimaging biomarkers are a prominent
strategy used in AD/ADRD research to detect AD pathology, provide insights into disease mechanism and
heterogeneity, track disease progression and, ultimately, monitor the efficacy of disease-modifying
interventions. Neuroimaging methods can also noninvasively assess other neuropathophysiological
mechanisms such as neurovascular insufficiency and neuroinflammation that are implicated as mechanisms
and modulators of AD and therefore likely contribute to the heterogeneity observed in its risk, incidence, and
progression. When linked to postmortem measures of proteinopathy burden, imaging measures can shed light
on heterogeneity of AD/ADRD, allowing for discovery of in vivo signatures of “pure AD” and concomitant non-
AD pathologies.
The Penn ADRC Neuroimaging Core will consolidate expertise in advanced neuroimaging methods and
applications to support the acquisition and analysis of state-of-the-art multimodal MRI of brain structure and
function, molecular brain imaging using PET, retinal angiography using optical coherence tomography (OCTA).
The Neuroimaging Core will oversee the acquisition and analysis of standard MRI and PET scans used in
defining preclinical AD based on amyloid, tau, and neurodegeneration (“A/T/(N)”) staging and for quantifying
ischemic lesions in the brain. Additional unique features of the Neuroimaging Core include the use of ultra-
high-field (7T) MRI both in vivo and for post-mortem imaging of intact hemispheres, the development methods
for accurate image-guided sampling of post-mortem brain tissue allowing spatial linkage between digital
pathology and in vivo morphometry, the development a data infrastructure linking imaging and non-imaging
databases, novel MRI and OCT methods for quantifying brain structure and vascular function in ADRC
research, and infrastructure to support the translation of novel PET tracers to clinical research in AD/ADRD.
The Neuroimaging Core will also share imaging data collected at the Penn ADRC with the NACC Coordinating
Center at the University of Washington and SCAN U24.
The Neuroimaging Core will be highly integrated with other ADRC cores, providing access to advanced
imaging and derived imaging metrics for the Clinical Core, collaboration on image analysis and databasing of
image-based information with the Data Management and Statistics Core, linking in vivo and postmortem
neuroimaging to neuropathology in conjunction with the Neuropathology Core, leveraging imaging as a means
of linking genetic factors with structural and functional brain phenotype with Genomics Core, working with the
Outreach Recruitment and Engagement Core to provide research updates about neuroimaging advances and
promote participation in imaging studies, and providing education and training in neuroimaging through
Research Education Component.
神经影像学核心项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN A DETRE其他文献
JOHN A DETRE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN A DETRE', 18)}}的其他基金
Cross-disciplinary training in translational neuroimaging of ADRD
ADRD 转化神经影像学跨学科培训
- 批准号:
10411110 - 财政年份:2022
- 资助金额:
$ 70.91万 - 项目类别:
Serial Physiologic MRI in Minor Stroke with Large Vessel Occlusion
伴有大血管闭塞的小中风的系列生理 MRI
- 批准号:
10432419 - 财政年份:2022
- 资助金额:
$ 70.91万 - 项目类别:
Cross-disciplinary training in translational neuroimaging of ADRD
ADRD 转化神经影像学跨学科培训
- 批准号:
10617812 - 财政年份:2022
- 资助金额:
$ 70.91万 - 项目类别:
Serial Physiologic MRI in Minor Stroke with Large Vessel Occlusion
伴有大血管闭塞的小中风的系列生理 MRI
- 批准号:
10598577 - 财政年份:2022
- 资助金额:
$ 70.91万 - 项目类别:
Novel Biomarkers of Small Vessel Contributions to Vascular Cognitive Impairment and Dementia (VCID)
小血管对血管认知障碍和痴呆 (VCID) 贡献的新型生物标志物
- 批准号:
10436194 - 财政年份:2019
- 资助金额:
$ 70.91万 - 项目类别:
Novel Biomarkers of Small Vessel Contributions to Vascular Cognitive Impairment and Dementia (VCID)
小血管对血管认知障碍和痴呆 (VCID) 贡献的新型生物标志物
- 批准号:
10201780 - 财政年份:2019
- 资助金额:
$ 70.91万 - 项目类别:
Novel Biomarkers of Small Vessel Contributions to Vascular Cognitive Impairment and Dementia (VCID)
小血管对血管认知障碍和痴呆 (VCID) 贡献的新型生物标志物
- 批准号:
10683733 - 财政年份:2019
- 资助金额:
$ 70.91万 - 项目类别:














{{item.name}}会员




